Capital Performance Advisors »

Neumora Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $144 11 13.18

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics